Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$209.01 - $232.56 $22.8 Million - $25.4 Million
-109,261 Reduced 1.12%
9,636,396 $2.11 Billion
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $88.3 Million - $102 Million
-446,792 Reduced 4.38%
9,745,657 $2.22 Billion
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $26.8 Million - $29.6 Million
-133,387 Reduced 1.29%
10,192,449 $2.05 Billion
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $19 Million - $21.7 Million
-89,746 Reduced 0.86%
10,325,836 $2.49 Billion
Q1 2023

Jul 14, 2023

BUY
$213.32 - $257.83 $83,621 - $101,069
392 Added 0.0%
10,415,582 $2.39 Billion
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $7.45 Million - $9 Million
-34,925 Reduced 0.33%
10,415,190 $2.39 Billion
Q4 2022

Feb 10, 2023

SELL
$203.72 - $248.97 $34.7 Million - $42.4 Million
-170,377 Reduced 1.6%
10,450,115 $2.46 Billion
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $41.5 Million - $53.1 Million
-202,438 Reduced 1.87%
10,620,492 $2.18 Billion
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $7.74 Million - $10.1 Million
-36,198 Reduced 0.33%
10,822,930 $2.54 Billion
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $27.6 Million - $31.6 Million
106,063 Added 0.99%
10,859,128 $2.86 Billion
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $25.5 Million - $29.5 Million
-93,952 Reduced 0.87%
10,753,065 $3.38 Billion
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $13.5 Million - $15.1 Million
-48,945 Reduced 0.45%
10,847,017 $3.05 Billion
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $2.74 Billion - $3.03 Billion
10,895,962 New
10,895,962 $3.01 Billion

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.